Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Although weight-loss specific drugs are now licensed, supply is limited, and as a consequence, off-label prescribing of diabetic drugs has continued to grow (particularly of Ozempic (active ingredient: semaglutide) and Mounjaro (active ingredient: tirzepatide))
Leave your questions and comments below
Protocol: GHRP-6: 100 mcg per injection Mod GRF 1-29: 100 mcg per injection Frequency: 2-3 times daily (same timing, mixed in the same syringe or injected sequentially) Timing: Upon waking (fasted), post-workout, and before bed (fasted) Cycle length: 12-16 weeks The short half-life of Mod GRF 1-29 (without DAC) matches GHRP-6 pulsatile release profile
Semaglutide is typically prescribed for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related condition such as high blood pressure or type 2 diabetes
US$ 20.20
US$ 23.73
.png)
US$ 27.27
US$ 26.83
US$ 28.49
US$ 28.34
US$ 23.86
